Citigroup’s PDS Biotechnology PDSB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-20
| Closed | -$33 | – | 4934 |
|
|
2024
Q4 | $33 | Sell |
20
-2
| -9% | -$3 | ﹤0.01% | 4864 |
|
|
2024
Q3 | $84 | Sell |
22
-23,481
| -100% | -$89.7K | ﹤0.01% | 4715 |
|
|
2024
Q2 | $68.9K | Buy |
23,503
+18,719
| +391% | +$54.8K | ﹤0.01% | 3683 |
|
|
2024
Q1 | $18.9K | Buy |
4,784
+770
| +19% | +$3.05K | ﹤0.01% | 4289 |
|
|
2023
Q4 | $20K | Buy |
4,014
+3,997
| +23,512% | +$19.9K | ﹤0.01% | 4235 |
|
|
2023
Q3 | $86 | Sell |
17
-8,310
| -100% | -$42K | ﹤0.01% | 4674 |
|
|
2023
Q2 | $41.9K | Buy |
8,327
+8,067
| +3,103% | +$40.6K | ﹤0.01% | 4056 |
|
|
2023
Q1 | $1.6K | Hold |
260
| – | – | ﹤0.01% | 4394 |
|
|
2022
Q4 | $3.43K | Buy |
+260
| New | +$3.43K | ﹤0.01% | 4361 |
|
|
2022
Q1 | – | Sell |
-1,870
| Closed | -$15K | – | 5574 |
|
|
2021
Q4 | $15K | Buy |
1,870
+1,080
| +137% | +$8.66K | ﹤0.01% | 4704 |
|
|
2021
Q3 | $12K | Sell |
790
-210
| -21% | -$3.19K | ﹤0.01% | 4664 |
|
|
2021
Q2 | $13K | Buy |
+1,000
| New | +$13K | ﹤0.01% | 4862 |
|
|
2018
Q2 | – | Sell |
-125
| Closed | -$3K | – | 5050 |
|
|
2018
Q1 | $3K | Buy |
125
+74
| +145% | +$1.78K | ﹤0.01% | 4707 |
|
|
2017
Q4 | $10K | Buy |
51
+48
| +1,600% | +$9.41K | ﹤0.01% | 4508 |
|
|
2017
Q3 | $1K | Sell |
3
-4
| -57% | -$1.33K | ﹤0.01% | 4609 |
|
|
2017
Q2 | $1K | Buy |
7
+3
| +75% | +$429 | ﹤0.01% | 4730 |
|
|
2017
Q1 | $1K | Sell |
4
-814
| -100% | -$204K | ﹤0.01% | 4724 |
|
|
2016
Q4 | $204K | Buy |
+818
| New | +$204K | ﹤0.01% | 3557 |
|
|
2016
Q3 | – | Sell |
-81
| Closed | -$16K | – | 4961 |
|
|
2016
Q2 | $16K | Sell |
81
-264
| -77% | -$52.1K | ﹤0.01% | 4293 |
|
|
2016
Q1 | $64K | Buy |
345
+218
| +172% | +$40.4K | ﹤0.01% | 4172 |
|
|
2015
Q4 | $32K | Buy |
+127
| New | +$32K | ﹤0.01% | 4315 |
|